Brief: Cannara Biotech Q2 EPS CAD 0.04
28/04/2025 12:00
Apr 28 (Reuters) - Cannara Biotech Q2 revenue CAD 26.6 million. Q2 net income CAD 6.7 million
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04